IONIC,BIOCHEMICAL,GENETIC BASIS FOR CYCLOSPORIN ACTIVITY
IONIC,BIOCHEMICAL,GENETIC BASIS FOR CYCLOSPORIN ACTIVITY
批准号:
3140239
负责人:
ERWIN William GELFAND
金额:
$14.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1992-06-30
关键词:
B lymphocyte T lymphocyte biological signal transduction calcium flux cell population study cyclosporines drug interactions drug metabolism flow cytometry fluorescent dye /probe genetic regulation human subject immunoconjugates immunosuppressive interleukin 2 ion transport membrane potentials protein biosynthesis receptor expression tissue /cell culture
中文摘要
环孢素A (Cyclosporin A, CsA)是一种有效的免疫抑制剂
英文摘要
Cyclosporin A (CsA) is a potent immunosuppressive agent, which acts
primarily by inhibiting T cell function, likely by preventing IL2
formation. Its wide and successful use in clinical transplantation
requires a more accurate definition of its mode of action. The
presumption that CsA selectively blocks IL2 production ignores the
inhibition readily demonstrated on earlier metabolic events and its
suppressive activity in B lymphocytes as well. We have
demonstrated that the immunosuppressive cyclosporins, but not the
non-immunosuppressive analog, affect ion mobilization and the
resting membrane potential of cells, resulting in decreased
intracellular Ca2+ concentrations. These findings, which are the
earliest recorded effect of the drugs, likely contribute to the
overall immunosuppressive activities of this group of drugs,
especially on IL2 production and T-cell proliferation. The goals
of the present proposal are to further define the ionic,
biochemical, and genetic basis for cyclosporin-dependent effects
on membrane potential, Ca2+ uptake and IL2 formation, to determine
the interrelationship between these phenomena, and to delineate the
requirements for their immunosuppressive action. Specifically in
human T and B cells we will examine early activation events
following receptor-ligand interaction, subsequent events which
occur after a signal has reached the nucleus, and late events
associated with cell division, lymphokine production or Ig
secretion. Using intracellularly trapped fluorescent indicators
we will monitor changes in cytosolic Ca2+ concentrations, cytosolic
pH, and membrane potential. We will determine if the major effects
of the cyclosporins are mediated through alteration of K+
permeability. We will assess the consequences of altering early
biochemical events including phosphoinositide metabolism on the
expression of c-fos, c-myc, IL2, IL2 receptor and transferrin
receptor gene mRNA and ultimately on receptor expression, IL2
formation and cell proliferation or Ig secretion. In an attempt
to define activities of specific T-cell subsets we will obtain T-
cell subsets by sorting and will couple the drugs to liposomes and
target them to specific lymphocyte subsets with monoclonal
antibodies. More precise definition of the mechanism of action of
the cyclosporins would provide further understanding for its use
as an immunosuppressive agent, offering the potential for combining
it with other forms of therapy and possibly reducing dosage,
duration and hence toxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LTB4-BLT1 Interactions in the Pathogenesis of Allergic Airway Disease
-
批准号:8147497
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2010
-
负责人:ERWIN William GELFAND
-
依托单位:
Administrative Core A
-
批准号:8147505
-
项目类别:
-
资助金额:$32.44万
-
财政年份:2010
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:7910663
-
项目类别:
-
资助金额:$46.89万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Antenatal Dietary Supplementation is a Risk Factor for Infant Atopy Through Epige
-
批准号:7821778
-
项目类别:
-
资助金额:$49.99万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Antenatal Dietary Supplementation is a Risk Factor for Infant Atopy Through Epige
-
批准号:7942064
-
项目类别:
-
资助金额:$43.09万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:7729164
-
项目类别:
-
资助金额:$45.89万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:8310977
-
项目类别:
-
资助金额:$46.83万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:8503580
-
项目类别:
-
资助金额:$45.11万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally Occurring T Regulatory Cells Control Airway Hyperresponsiveness
-
批准号:8085839
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2009
-
负责人:ERWIN William GELFAND
-
依托单位:
Naturally occurring T regulatory cells control airway hyperresponsiveness
-
批准号:7683378
-
项目类别:
-
资助金额:$48.67万
-
财政年份:2008
-
负责人:ERWIN William GELFAND
-
依托单位:
Administrative Core
-
批准号:7255196
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2007
-
负责人:ERWIN William GELFAND
-
依托单位:
LTB4-BLT1 Interactions in the Pathogenesis of Allergic Airway Disease
-
批准号:7255194
-
项目类别:
-
资助金额:$58.24万
-
财政年份:2007
-
负责人:ERWIN William GELFAND
-
依托单位:
ROLE OF T LYMPHOCYTES IN AIRWAY HYPERRESPONSIVENESS
-
批准号:6612395
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2002
-
负责人:ERWIN William GELFAND
-
依托单位:
ROLE OF T LYMPHOCYTES IN AIRWAY HYPERRESPONSIVENESS
-
批准号:6327724
-
项目类别:
-
资助金额:$28.58万
-
财政年份:2000
-
负责人:ERWIN William GELFAND
-
依托单位:
RSV ENHANCES SENSITIZATION AND AIRWAY RESPONSIVENESS
-
批准号:6184904
-
项目类别:
-
资助金额:$28.72万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
RSV ENHANCES SENSITIZATION AND AIRWAY RESPONSIVENESS
-
批准号:6390055
-
项目类别:
-
资助金额:$29.41万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
Age-Dependent Increases in Airway Responsiveness by RSV
-
批准号:7226658
-
项目类别:
-
资助金额:$32.34万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
Age-Dependent Increases in Airway Responsiveness by RSV
-
批准号:6895611
-
项目类别:
-
资助金额:$34.11万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
RSV ENHANCES SENSITIZATION AND AIRWAY RESPONSIVENESS
-
批准号:2858661
-
项目类别:
-
资助金额:$28.01万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
Age-Dependent Increases in Airway Responsiveness by RSV
-
批准号:7035277
-
项目类别:
-
资助金额:$33.31万
-
财政年份:1999
-
负责人:ERWIN William GELFAND
-
依托单位:
海外基金